OVARIAN CANCER and US: abstract: Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?

OVARIAN CANCER and US

An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.

“Not everything that can be counted counts and not everything that counts can be counted.”

Albert Einstein

Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Monday, September 06, 2010

abstract: Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?

"PLD is cardiac safe for long-term treatment of metastatic solid tumors. Its maximal cumulative dose remains undefined. "

OvarianCancerandUs

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

View web version

Sandi Pniauskas Ovarian Cancer and Us

OvarianCancerandUs

View my complete profile

Powered by Blogger.